Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $787,942 | $34,518 | $34,374 | $33,565 |
| - Cash | $278,995 | $298,036 | $485,843 | $774,396 |
| + Debt | $493,589 | $369,089 | $498,241 | $826,186 |
| Enterprise Value | $1,002,536 | $105,571 | $46,772 | $85,355 |
| Revenue | $187,137 | $240,113 | $230,720 | $235,763 |
| % Growth | -22.1% | 4.1% | -2.1% | – |
| Gross Profit | $137,988 | $185,986 | $181,760 | $187,956 |
| % Margin | 73.7% | 77.5% | 78.8% | 79.7% |
| EBITDA | -$122,182 | -$450,207 | -$162,750 | -$208,730 |
| % Margin | -65.3% | -187.5% | -70.5% | -88.5% |
| Net Income | -$134,772 | -$507,820 | -$206,487 | -$353,566 |
| % Margin | -72% | -211.5% | -89.5% | -150% |
| EPS Diluted | -0.31 | -1.16 | -0.47 | -0.81 |
| % Growth | 73.3% | -146.8% | 42% | – |
| Operating Cash Flow | $0 | -$58,509 | $82,248 | -$278,703 |
| Capital Expenditures | $0 | $2,002 | -$43,558 | -$207,347 |
| Free Cash Flow | $0 | -$56,507 | $38,690 | -$486,050 |